01 1Chongqing Huapont Pharmaceutical
01 1BENDAMUSTINE HCI MONOHYDRATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-10
Pay. Date : 2015-04-28
DMF Number : 29095
Submission : 2015-02-11
Status : Active
Type : II
20
Chongqing Huapont Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BENDAMUSTINE HCI MONOHYDRATE, with a corresponding US DMF Number 29095.
Remarkably, this DMF maintains an Active status since its submission on February 11, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 10, 2016, and payment made on April 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
